Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2020

Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience
Authors: V. Sandecka, Z. Adam, M. Krejci, M. Stork, Z. Rehak, R. Koukalova, S. Sevcikova, L. Brozova, Z. Kral, J. Mayer, L. Pour
Neoplasma Vol.67, No.4, p.939–945, 2020
doi:10.4149/neo_2020_191104N1137
[View Abstract]


The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL
Authors: M. Kicova, Z Michalova, M. Coma, J. Gabzdilova, K. Dedinska, T. Guman, S. Bernatova, M. Hajikova, M. Giertlova, D. Veselinyova, M. Sarissky
Neoplasma Vol.67, No.4, p.933–938, 2020
doi:10.4149/neo_2020_190826N822
[View Abstract]


Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: A prospective study
Authors: W. S. Chen, Y. S. Huang, L. B. Xu, M. M. Shi, X. D. Chen, G. Q. Ye, T. T. Wu, G. B. Zhu
Neoplasma Vol.67, No.4, p.922–932, 2020
doi:10.4149/neo_2020_190908N882
[View Abstract]


Study of DOK4 gene expression and promoter methylation in sporadic breast cancer
Authors: A. Heidarizadi, M. Salimi, H. Mozdarani
Neoplasma Vol.67, No.4, p.916–921, 2020
doi:10.4149/neo_2020_190811N747
[View Abstract]


Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma
Authors: M. M. Chen, R. C. Zhao, K. F. Chen, Y. Huang, Z. J. Liu, Y. G. Wei, Y. Jian, A. M. Sun, L. Qin, B. Li, Y. Qin
Neoplasma Vol.67, No.4, p.909–915, 2020
doi:10.4149/neo_2020_190819N789
[View Abstract]


Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors
Authors: S. Shinriki, M. Maeshiro, K. Shimamura, J. Kawashima, E. Araki, M. Ibusuki, Y. Yamamoto, H. Iwase, Y. Miyamoto, H. Baba, M. Yamaguchi, H. Matsui
Neoplasma Vol.67, No.4, p.898–908, 2020
doi:10.4149/neo_2020_190918N925
[View Abstract]


Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway
Authors: H. Wei, C. Dong, Z. Shen
Neoplasma Vol.67, No.4, p.889–897, 2020
doi:10.4149/neo_2020_190814N758
[View Abstract]


O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells
Authors: L. Jin, M.h. Lu, G. C. Dai, Q. Yao, H. Xiang, L. X. Wang, B.x. Xue, X. L. Liu
Neoplasma Vol.67, No.4, p.880–888, 2020
doi:10.4149/neo_2020_191006N1009
[View Abstract]


LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis
Authors: Z. Qiu, X. X. Pan, D.y. You
Neoplasma Vol.67, No.4, p.871–879, 2020
doi:10.4149/neo_2020_190826N821
[View Abstract]


Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p
Authors: J. H. Yuan, W. X. Li, C. Hu, B. Zhang
Neoplasma Vol.67, No.4, p.861–870, 2020
doi:10.4149/neo_2020_190808N731
Price: free access
[View Abstract]


The tumor suppressor NOR1 suppresses cell growth, invasiveness, and tumorigenicity in glioma
Authors: J. Cai, C. Liu, M. Yi, Y. Tan, S. Chen, N. Ren, H. Cheng, X. Li, W. Xiong, G. Li, M. Wu, W. Wang, B. Xiang
Neoplasma Vol.67, No.4, p.851–860, 2020
doi:10.4149/neo_2020_190724N661
[View Abstract]


Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27
Authors: J. Li, Z. G. Lian,Y. H. Xu, R. Y. Liu, Z. Q. Wei, T. Li, H.t. Lv, Y. S. Zhao, Y. J. Liu, B. Dong, X. Fu
Neoplasma Vol.67, No.4, p.843–850, 2020
doi:10.4149/neo_2020_190814N759
[View Abstract]


Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
Authors: X. X. Jiao, S. Y. Lin, S. X. Lian, Y. R. Qiu, Z. H. Li, Z. H. Chen, W. Q. Lu, Y. Zhang, L. Deng, Y. Jiang, G. H. Hu
Neoplasma Vol.67, No.4, p.834–842, 2020
doi:10.4149/neo_2020_190805N716
[View Abstract]


miR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer
Authors: S. Wang, Y. J. Diao, B. B. Zhu
Neoplasma Vol.67, No.4, p.825–833, 2020
doi:10.4149/neo_2020_190730N687
[View Abstract]


miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2
Authors: Z. R. Zhang, N. Yang
Neoplasma Vol.67, No.4, p.813–824, 2020
doi:10.4149/neo_2020_190823N811
[View Abstract]


The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells
Authors: C. M. Wei, X. F. Zhao, H. B. Qiu, Z. Ming, K. Liu, J. Yan
Neoplasma Vol.67, No.4, p.802–812, 2020
doi:10.4149/neo_2020_190723N657
[View Abstract]


SOCS2 affects the proliferation, migration, and invasion of nasopharyngeal carcinoma cells via regulating EphA1
Authors: B. Dai, X. Zhang
Neoplasma Vol.67, No.4, p.794–801, 2020
doi:10.4149/neo_2020_190807N724
[View Abstract]


LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis
Authors: C. Xu, J. Zhai, Y. Fu
Neoplasma Vol.67, No.4, p.782–793, 2020
doi:10.4149/neo_2020_190617N515
[View Abstract]


miR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells
Authors: J. Ye, X. Xiao, Y. Han, D. Fan, Y. Zhu, L. Yang
Neoplasma Vol.67, No.4, p.773–781, 2020
doi:10.4149/neo_2020_190730N689
[View Abstract]


Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway
Authors: L. Zhang, Y. Wang, H. Su
Neoplasma Vol.67, No.4, p.762–772, 2020
doi:10.4149/neo_2020_190706N598
[View Abstract]





Display #  
Results 1 - 20 of 105

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.